Impulse Dynamics Archives | Page 2 of 2 | Be Korea-savvy
Impulse Dynamics Announces 9,000th Patient Milestone Achieved with CCM® Therapy for Heart Failure

Impulse Dynamics Announces 9,000th Patient Milestone Achieved with CCM® Therapy for Heart Failure

MARLTON, N.J., May 15 (Korea Bizwire) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a worldwide milestone achievement with the 9,000th patient receiving the Optimizer® system for the treatment of moderate HF. The Optimizer system is the only device approved by the [...]

Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy

Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy

MARLTON, N.J., Nov. 16 (Korea Bizwire) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, announced the 100th implant in China, signifying the opportunity for its innovative Optimizer® system delivering CCM® therapy in markets around the world. Cardiologist Prof. Guo Tao, Executive Director of Internal Medicine, Fuwai [...]

Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy

Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy

MARLTON, N.J., June 14 (Korea Bizwire) — Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCM therapy to people with heart failure, announced that the first implants in Europe for the newly launched Optimizer® Smart Mini device were recently completed in Italy. The company announced the launch of the new technology on [...]

Late-breaking Results Show Efficacy for CCM in Patients with HFpEF

Late-breaking Results Show Efficacy for CCM in Patients with HFpEF

MADRID and MARLTON, N.J., May 23 (Korea Bizwire) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a late-breaking presentation of results from the CCM-HFpEF Piloty Study, which is the largest clinical trial to date studying the effects of the company’s proprietary CCM® [...]